眼科用PACS(画像保存通信システム)の世界市場予測(~2023年)

◆英語タイトル:Ophthalmology PACS (Picture Archiving and Communication System) Market by Type (Standalone, Integrated), Delivery (On-premise, Cloud), End User (Hospitals, Specialty Clinic, ASC), Region (North America (US, Canada) Europe, Asia) - Global Forecast to 2023
◆商品コード:HIT6515
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2018年8月8日
◆ページ数:135
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

MarketsandMarketsが発行した当調査レポートでは、眼科用PACS(画像保存通信システム)の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別(スタンドアロン型、統合型)分析、デリバリ別(オンプレミス、クラウド)分析、エンドユーザー別(病院、専門クリニック、通院外科診療所)分析、眼科用PACS(画像保存通信システム)の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

“The global ophthalmology PACS market is projected to grow at 8.5% during the forecast period.”
The global ophthalmology PACS market is projected to reach USD 160.2 million by 2023 from an estimated USD 106.6 million in 2018, at a CAGR of 8.5% during the forecast period. Growth in this market is mainly driven by the rapid growth in the geriatric population, rising prevalence of eye diseases, limited number of ophthalmologists, government initiatives to encourage the adoption of EHR/EMR, and the increasing adoption of teleophthalmology. On the other hand, high implementation and maintenance costs are expected to limit market growth during the forecast period. Poor compatibility with informatics standards may also challenge market growth to a certain extent.

“By delivery model, web/cloud-based models are expected to grow at the highest CAGR during the forecast period.”
On the basis of delivery model, the ophthalmology PACS market is segmented into on-premise and web/cloud-based models. The web/cloud-based PACS segment is expected to grow at the highest CAGR during the forecast period. Cloud-based models do not incur any major setup charges. Additionally, the maintenance and support service charges are also inclusive of the subscription fees, making these delivery modes more affordable for customers.
“Asia to witness high growth during the forecast period.”
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to grow at the highest CAGR during the forecast period. The high growth of this regional segment is attributed to the increasing demand for diagnostic imaging procedures, growing medical tourism, increasing geriatric population and incidence of age-related eye diseases, growing awareness on healthcare services, rising healthcare expenditure, and developing healthcare infrastructure.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 30%; Tier 2 – 42%; Tier 3 – 28%.
• By Designation: C-level- 25%; D-level- 45%; others–30%.
• By Region: North America-34%; Europe-28%; Asia -32%; RoW-6%.
List of companies profiled in the report
• Carl Zeiss Meditec AG (Germany)
• Topcon Corporation (Japan)
• Heidelberg Engineering (Germany)
• Sonomed Escalon (US)
• Visbion (UK)
• EyePACS (US)
• IBM Corporation (Merge Healthcare) (US)
• VersaSuite (US)
• Medical Standard (South Korea)
• ScImage (US)
Research Coverage:
The report provides an overview of the ophthalmology PACS market. It aims at estimating the market size and growth potential of this market across different segments such as type, delivery model, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in the ophthalmology PACS market by providing them with the closest approximations of revenues for the overall market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies adopt suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 YEARS CONSIDERED FOR THE STUDY 17
1.3.2 MARKETS COVERED 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 20
2.1.2.1 Key data from primary sources 21
2.2 MARKET SIZE ESTIMATION 22
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 28
4.1 OPHTHALMOLOGY PACS: MARKET OVERVIEW 28
4.2 OPHTHALMOLOGY PACS MARKET, BY TYPE, 2018–2023 28
4.3 OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2018 VS. 2023 (USD MILLION) 29
4.4 OPHTHALMOLOGY PACS MARKET, BY END USER (2018) 29
4.5 GEOGRAPHICAL SNAPSHOT OF THE OPHTHALMOLOGY PACS MARKET 30
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.2 MARKET DYNAMICS 31
5.2.1 DRIVERS 32
5.2.1.1 Rapid growth in the geriatric population 32
5.2.1.2 Rising prevalence of eye diseases 32
5.2.1.3 Limited number of ophthalmologists 33
5.2.1.4 Government initiatives to encourage adoption of EHR/EMR 33
5.2.1.5 Expansion of teleophthalmology 34

5.2.2 RESTRAINTS 34
5.2.2.1 High implementation and maintenance costs 34
5.2.3 OPPORTUNITIES 35
5.2.3.1 Untapped emerging markets 35
5.2.3.2 Integration with EHR/EMR 35
5.2.3.3 High-growth opportunities represented by cloud-based platforms 36
5.2.4 CHALLENGES 36
5.2.4.1 Poor compatibility with informatics standards 36
6 INDUSTRY INSIGHTS 37
6.1 NEW VS. REPLACEMENT MARKET 37
6.2 PACS VS. VENDOR NEUTRAL PACS 38
6.3 OPHTHALMOLOGISTS VS. OPTOMETRISTS 39
6.4 MARKET ENTRY STRATEGY 39
6.4.1 KEY FUNCTIONALITIES REQUIRED: 40
6.5 LIST OF OPHTHALMOLOGY/OPTOMETRY PRACTICES, BY REGION 40
7 OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL 45
7.1 INTRODUCTION 46
7.2 ON-PREMISE MODEL 47
7.3 WEB/CLOUD-BASED MODELS 49
8 OPHTHALMOLOGY PACS MARKET, BY TYPE 52
8.1 INTRODUCTION 53
8.2 INTEGRATED PACS 54
8.3 STANDALONE PACS 56
9 OPHTHALMOLOGY PACS MARKET, BY END USER 58
9.1 INTRODUCTION 59
9.2 SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS (ASCS) 60
9.3 HOSPITALS 62
9.4 OTHER END USERS 65
10 OPHTHALMOLOGY PACS MARKET, BY REGION 67
10.1 INTRODUCTION 68
10.2 NORTH AMERICA 69
10.2.1 US 72
10.2.2 CANADA 74

10.3 EUROPE 76
10.3.1 GERMANY 79
10.3.2 FRANCE 80
10.3.3 UK 82
10.3.4 ROE 84
10.4 ASIA 86
10.4.1 JAPAN 88
10.4.2 CHINA 90
10.4.3 INDIA 92
10.4.4 SINGAPORE 93
10.4.5 REST OF ASIA (ROA) 95
10.5 PACIFIC COUNTRIES 96
10.6 REST OF THE WORLD 98
11 COMPETITIVE LANDSCAPE 100
11.1 OVERVIEW 100
11.2 MARKET SHARE ANALYSIS 101
11.3 COMPETITIVE SCENARIO 103
11.3.1 EXPANSIONS (2015–2018) 103
11.3.2 MERGERS AND ACQUISITIONS (2015–2018) 103
11.3.3 PRODUCT LAUNCHES AND ENHANCEMENTS (2015–2018) 104
11.3.4 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS (2015–2018) 105
12 COMPANY PROFILES 106
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 IBM CORPORATION (MERGE HEALTHCARE INCORPORATED) 106
12.2 CARL ZEISS MEDITEC AG 109
12.3 TOPCON CORPORATION 112
12.4 HEIDELBERG ENGINEERING 115
12.5 SONOMED ESCALON 117
12.6 VISBION 119
12.7 EYEPACS 120
12.8 VERSASUITE 121
12.9 MEDICAL STANDARD 122
12.10 SCIMAGE 123
12.11 AGFA-GEVAERT GROUP 124
12.12 CANON USA, INC. 126
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

13 APPENDIX 128
13.1 INSIGHTS FROM INDUSTRY EXPERTS 128
13.2 DISCUSSION GUIDE 129
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 131
13.4 AVAILABLE CUSTOMIZATIONS 133
13.5 RELATED REPORTS 133
13.6 AUTHOR DETAILS 134

LIST OF TABLES

TABLE 1 PROJECTED INCREASE IN GERIATRIC POPULATION, 2000 TO 2050 32
TABLE 2 PREVALENCE OF LEADING EYE DISEASES AMONG ADULTS
ABOVE 40 YEARS OF AGE) IN THE US 33
TABLE 3 OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 46
TABLE 4 ON-PREMISE OPHTHALMOLOGY PACS MARKET, BY REGION,
2016–2023 (USD MILLION) 47
TABLE 5 NORTH AMERICA: ON-PREMISE OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 47
TABLE 6 EUROPE: ON-PREMISE OPHTHALMOLOGY PACS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 48
TABLE 7 ASIA: ON-PREMISE OPHTHALMOLOGY PACS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 48
TABLE 8 WEB/CLOUD-BASED OPHTHALMOLOGY PACS MARKET, BY REGION,
2016–2023 (USD MILLION) 49
TABLE 9 NORTH AMERICA: WEB/CLOUD-BASED OPHTHALMOLOGY PACS MARKET,
2016–2023 (USD MILLION) 50
TABLE 10 EUROPE: WEB/CLOUD-BASED OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 50
TABLE 11 ASIA: WEB/CLOUD-BASED OPHTHALMOLOGY PACS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 51
TABLE 12 OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 53
TABLE 13 INTEGRATED OPHTHALMOLOGY PACS MARKET, BY REGION,
2016–2023 (USD MILLION) 54
TABLE 14 NORTH AMERICA: INTEGRATED OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 54
TABLE 15 EUROPE: INTEGRATED OPHTHALMOLOGY PACS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 55
TABLE 16 ASIA: INTEGRATED OPHTHALMOLOGY PACS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 55
TABLE 17 STANDALONE OPHTHALMOLOGY PACS MARKET, BY REGION,
2016–2023 (USD MILLION) 56
TABLE 18 NORTH AMERICA: STANDALONE OPHTHALMOLOGY PACS MARKET,
2016–2023 (USD MILLION) 56
TABLE 19 EUROPE: STANDALONE OPHTHALMOLOGY PACS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 57
TABLE 20 ASIA: STANDALONE OPHTHALMOLOGY PACS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 57
TABLE 21 OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION) 59
TABLE 22 OPHTHALMOLOGY PACS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY REGION, 2016–2023 (USD MILLION) 60
TABLE 23 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016–2023 (USD MILLION) 61
TABLE 24 EUROPE: OPHTHALMOLOGY PACS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016–2023 (USD MILLION) 61
TABLE 25 ASIA: OPHTHALMOLOGY PACS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016–2023 (USD MILLION) 62
TABLE 26 OPHTHALMOLOGY PACS MARKET FOR HOSPITALS, BY REGION,
2016–2023 (USD MILLION) 63
TABLE 27 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION) 63
TABLE 28 EUROPE: OPHTHALMOLOGY PACS MARKET FOR HOSPITALS, BY COUNTRY,
2016–2023 (USD MILLION) 64
TABLE 29 ASIA: OPHTHALMOLOGY PACS MARKET FOR HOSPITALS, BY COUNTRY,
2016–2023 (USD MILLION) 64
TABLE 30 OPHTHALMOLOGY PACS MARKET FOR OTHER END USERS, BY REGION,
2016–2023 (USD MILLION) 65
TABLE 31 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET FOR OTHER END USERS,
BY COUNTRY, 2016–2023 (USD MILLION) 65
TABLE 32 EUROPE: OPHTHALMOLOGY PACS MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION) 66
TABLE 33 ASIA: OPHTHALMOLOGY PACS MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION) 66
TABLE 34 OPHTHALMOLOGY PACS MARKET, BY REGION, 2016–2023 (USD MILLION) 68
TABLE 35 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 71
TABLE 36 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET, BY TYPE,
2016–2023 (USD MILLION) 71
TABLE 37 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 71
TABLE 38 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET, BY END USER,
2016–2023 (USD MILLION) 72
TABLE 39 INCREASE IN DISEASE PREVALENCE, 2013 VS 2030 (MILLION PATIENTS) 72
TABLE 40 US: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 73
TABLE 41 US: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 73
TABLE 42 US: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION) 73
TABLE 43 CANADA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 74
TABLE 44 CANADA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 75
TABLE 45 CANADA: OPHTHALMOLOGY PACS MARKET, BY END USER,
2016–2023 (USD MILLION) 75
TABLE 46 EUROPE: OPHTHALMOLOGY PACS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 76
TABLE 47 EUROPE: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 78
TABLE 48 EUROPE: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 78
TABLE 49 EUROPE: OPHTHALMOLOGY PACS MARKET, BY END USER,
2016–2023 (USD MILLION) 78
TABLE 50 GERMANY: OPHTHALMOLOGY PACS MARKET, BY TYPE,
2016–2023 (USD MILLION) 79
TABLE 51 GERMANY: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 80
TABLE 52 GERMANY: OPHTHALMOLOGY PACS MARKET, BY END USER,
2016–2023 (USD MILLION) 80
TABLE 53 FRANCE: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 81
TABLE 54 FRANCE: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 81
TABLE 55 FRANCE: OPHTHALMOLOGY PACS MARKET, BY END USER,
2016–2023 (USD MILLION) 82
TABLE 56 UK: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 82
TABLE 57 UK: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 83
TABLE 58 UK: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION) 83
TABLE 59 ROE: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 84
TABLE 60 ROE: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 85
TABLE 61 ROE: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION) 85
TABLE 62 ASIA: OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 86
TABLE 63 ASIA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 87
TABLE 64 ASIA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 88
TABLE 65 ASIA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION) 88
TABLE 66 JAPAN: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 89
TABLE 67 JAPAN: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 89
TABLE 68 JAPAN: OPHTHALMOLOGY PACS MARKET, BY END USER,
2016–2023 (USD MILLION) 90
TABLE 69 CHINA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 91
TABLE 70 CHINA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 91
TABLE 71 CHINA: OPHTHALMOLOGY PACS MARKET, BY END USER,
2016–2023 (USD MILLION) 91
TABLE 72 INDIA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 92
TABLE 73 INDIA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 93
TABLE 74 INDIA: OPHTHALMOLOGY PACS MARKET, BY END USER,
2016–2023 (USD MILLION) 93
TABLE 75 SINGAPORE: OPHTHALMOLOGY PACS MARKET, BY TYPE,
2016–2023 (USD MILLION) 94
TABLE 76 SINGAPORE: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 94
TABLE 77 SINGAPORE: OPHTHALMOLOGY PACS MARKET, BY END USER,
2016–2023 (USD MILLION) 94
TABLE 78 ROA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 95
TABLE 79 ROA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 95
TABLE 80 ROA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION) 96
TABLE 81 PACIFIC COUNTRIES: OPHTHALMOLOGY PACS MARKET, BY TYPE,
2016–2023 (USD MILLION) 96
TABLE 82 PACIFIC COUNTRIES: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION) 97
TABLE 83 PACIFIC COUNTRIES: OPHTHALMOLOGY PACS MARKET, BY END USER,
2016–2023 (USD MILLION) 97
TABLE 84 ROW: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION) 98
TABLE 85 ROW: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL,
2016–2023 (USD MILLION) 99
TABLE 86 ROW: OPHTHALMOLOGY PACS MARKET, BY END USER,
2016–2023 (USD MILLION) 99




LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 19
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 21
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 22
FIGURE 4 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 23
FIGURE 5 INTEGRATED PACS TO DOMINATE THE OPHTHALMOLOGY PACS MARKET DURING THE FORECAST PERIOD 25
FIGURE 6 ON-PREMISE MODELS TO ACCOUNT FOR THE LARGEST SHARE OF THE OPHTHALMOLOGY PACS MARKET IN 2018 26
FIGURE 7 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 26
FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE OPHTHALMOLOGY PACS MARKET 27
FIGURE 9 RAPID GROWTH IN THE GERIATRIC POPULATION AND RISING PREVALENCE OF EYE DISEASES—KEY DRIVERS FOR MARKET GROWTH 28
FIGURE 10 INTEGRATED PACS TO REGISTER THE HIGHEST GROWTH RATE IN THE OPHTHALMOLOGY PACS MARKET BETWEEN 2018 AND 2023 28
FIGURE 11 WEB/CLOUD-BASED MODELS TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR MARKET PLAYERS 29
FIGURE 12 SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS SEGMENT TO HOLD THE LARGEST SHARE OF THE OPHTHALMOLOGY PACS MARKET IN 2018 29
FIGURE 13 MARKET IN ASIA PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018–2023) 30
FIGURE 14 OPHTHALMOLOGY PACS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 31
FIGURE 15 OPHTHALMOLOGY PACS: NEW VS. REPLACEMENT MARKET FOR OPHTHALMOLOGISTS AND OPTOMETRISTS - 2017 37
FIGURE 16 PACS VS VENDOR NEUTRAL PACS - 2018 VS 2023 38
FIGURE 17 OPHTHALMOLOGISTS VS. OPTOMETRISTS - 2017 39
FIGURE 18 WEB/CLOUD-BASED MODELS TO REGISTER THE HIGHEST GROWTH
DURING THE FORECAST PERIOD 46
FIGURE 19 INTEGRATED PACS TO REGISTER THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 53
FIGURE 20 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 59
FIGURE 21 NORTH AMERICA TO DOMINATE THE OPHTHALMOLOGY PACS MARKET IN 2018 68
FIGURE 22 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET SNAPSHOT 70
FIGURE 23 EUROPE: OPHTHALMOLOGY PACS MARKET SNAPSHOT 77
FIGURE 24 ASIA: OPHTHALMOLOGY PACS MARKET SNAPSHOT 87
FIGURE 25 KEY DEVELOPMENTS IN THE OPHTHALMOLOGY PACS MARKET BETWEEN
2015 AND 2018 100
FIGURE 26 MARKET EVOLUTION FRAMEWORK 101
FIGURE 27 OPHTHALMOLOGY PACS MARKET SHARE ANALYSIS, 2017 101
FIGURE 28 IBM: COMPANY SNAPSHOT (2017) 106
FIGURE 29 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2017) 109
FIGURE 30 TOPCON CORPORATION: COMPANY SNAPSHOT (2017) 112
FIGURE 31 SONOMED ESCALON: COMPANY SNAPSHOT (2017) 117
FIGURE 32 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2017) 124
FIGURE 33 CANON INC.: COMPANY SNAPSHOT (2017) 126



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[眼科用PACS(画像保存通信システム)の世界市場予測(~2023年)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆